Intellect Neurosciences, Inc., a biopharmaceutical company, engages in the research and development of proprietary drug candidates for the treatment of Alzheimer’'s disease. Dr. Daniel Chain, the CEO, is the inventor the platform being used by the world's leading pharmaceutical companies to find a treatment for Alzheimer's disease.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…